FDA approves once-daily bromfenac

FDA approved an sNDA from Ista Pharmaceuticals Inc. (NASDAQ:ISTA) for once-daily Bromday (formerly XiDay) bromfenac to treat ocular inflammation and pain following cataract surgery. Ista markets a twi...